Oral Mucositis in Oncopediatric Patients: MTX and MMP ‐1, MMP ‐8, MMP ‐13 Gene Polymorphisms
Oral Diseases · 2026-05 · 32 (5) · 1440-1450
DOI: 10.1111/odi.70195 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, online erschienen am 12.04.2026. Verfasst von Nicole Januário Ribeiro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, University Federal of Paraná, Curitiba, Paraná, Brazil. Hauptthemen laut MEDLINE: Matrix Metalloproteinase 8, Stomatitis, Methotrexate, Matrix Metalloproteinase 1. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
This study investigates the association between single‐nucleotide polymorphisms (SNPs) in the MMP‐1, MMP‐8, and MMP‐13 genes and the risk of oral mucositis development in paediatric patients with leukaemia and lymphoma who are undergoing methotrexate (MTX) treatment. MTX is associated with inflammatory effects and oxidative stress, which activate MMPs, enzymes responsible for degrading the extracellular matrix. This study aimed to investigate the association between MMPs polymorphisms (rs1799750, rs3025058, and rs2252070) with OM in the oncopediatric patients treated with MTX.
Methods
Genomic DNA from 100 patients was extracted from saliva and genotypes were obtained by PCR‐RFLP. Genotype data were measured using the Chi‐square test. Haplotype estimation, Hardy–Weinberg equilibrium, linkage disequilibrium, multiple logistic regression analyses was conducted using SNPStats and with R. MCA performed with the packages FactoMineR and factoextra.
Results
The results show that the MMP‐1 g.‐1607 G>GG, MMP‐8 g.‐799 C>T, and MMP‐13 g.‐77 A>G polymorphisms are associated with the occurrence of oral mucositis. The MMP‐8 g.‐799 C>T polymorphism was also associated with greater disease severity.
Conclusions
The study highlights the importance of these MMPs polymorphisms as potential markers for predicting susceptibility to oral mucositis, suggesting that these data could help tailor treatments to minimise the occurrence and severity of mucositis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology, University Federal of Paraná, Curitiba, Paraná, Brazil.
- Postgraduate Program in Decision Models and Health, Federal University of Paraíba, João Pessoa, Paraíba, Brazil.
- Department of Genetics, Federal University of Paraná, Curitiba, Paraná, Brazil.
- Department of Molecular Biology, Federal University of Paraíba, João Pessoa, Paraíba, Brazil.
- Department of Cell Biology, Federal University of Paraná, Curitiba, Paraná, Brazil.
ORCID-Profile: Maria Cristina Leme Godoy Santos
Zitieren
APA
Ribeiro, N. J., Tissi, L. H., Escobar, M. T., Valença, A. M. G., Souza, R. L. R., de Oliveira, N. F. P., & Santos, M. C. L. G. (2026). Oral Mucositis in Oncopediatric Patients: MTX and MMP ‐1, MMP ‐8, MMP ‐13 Gene Polymorphisms. Oral Diseases, 32(5), 1440-1450. https://doi.org/10.1111/odi.70195
Vancouver
Ribeiro NJ, Tissi LH, Escobar MT, Valença AMG, Souza RLR, de Oliveira NFP, et al. Oral Mucositis in Oncopediatric Patients: MTX and MMP ‐1, MMP ‐8, MMP ‐13 Gene Polymorphisms. Oral Diseases. 2026;32(5):1440-1450. doi:10.1111/odi.70195
BibTeX
@article{Ribeiro2026,
author = {Ribeiro, Nicole Januário and Tissi, Larissa Helena and Escobar, Mateus Tissot and Valença, Ana Maria Gondim and Souza, Ricardo Lehtonen Rodrigues and de Oliveira, Naila Francis Paulo and Santos, Maria Cristina Leme Godoy},
title = {Oral Mucositis in Oncopediatric Patients: MTX and MMP ‐1, MMP ‐8, MMP ‐13 Gene Polymorphisms},
journal = {Oral Diseases},
year = {2026},
volume = {32},
number = {5},
pages = {1440--1450},
doi = {10.1111/odi.70195}
}
EUVIMED